Moderna strikes deal to develop mRNA drugs in China
Publishing timestamp: 2023-07-05 09:19:31
Summary
Moderna has struck a deal with Chinese officials to research, develop, and manufacture messenger RNA medicines exclusively for the Chinese population. This deal comes despite rising tensions between the U.S. and China. Moderna is capitalizing on the success of its Covid vaccine, which uses mRNA technology. This is Moderna's first agreement with China and expands beyond Covid shots to include the development of mRNA medicines overall. The deal comes at a time when tensions between the U.S. and China are high, and the Biden administration is taking measures to diversify away from China in investment and trade.
Sentiment: NEUTRAL
Tickers: SAN-FR, NOVO.B-DK, PFE, AZN-GB, MRNA, MRK, GEHC,
Keywords: health care industry, biotechnology, sanofi sa, business news, pharmaceuticals, merck & co inc, novo nordisk a/s, foreign policy, ge healthcare technologies inc, china, pfizer inc, biotech and pharmaceuticals, moderna inc, astrazeneca plc, business,
Source: https://www.cnbc.com/2023/07/05/moderna-strikes-deal-to-develop-mrna-drugs-in-china-.html